ACTIVE

INNOVENTIS PHARMA

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result1,6 k €-62,0 %over 1 year
Gross margin689,5 k €+15,4 %over 1 year
Equity396,2 k €+0,4 %over 1 year
Workforce5,7 ETP+14,0 %over 1 year

Identity

Source · BCE/KBO

INNOVENTIS PHARMA is a Public limited company incorporated in 2018. Its main activity is: Wholesale of perfume and cosmetics. Its registered office is in Waasmunster. It employs on average 5,7 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0690.813.115
Incorporation
21/02/2018
Legal form
Public limited company
Registered office
Vierschaar 6
9250 Waasmunster · FlandreSee on map
Contributed capital
561 500,00 €
Latest accounts
31/12/2025
Average workforce
5,7 ETP
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 8 filings

Trend over 8 financial years

20252024202320222021
Income statement
Gross margin689,5 k €597,7 k €419,1 k €603,5 k €501,4 k €
EBITDA140,4 k €127,7 k €1,3 k €157,8 k €132,4 k €
Operating result8,8 k €6,1 k €-122,8 k €21,5 k €17,5 k €
Net result1,6 k €4,1 k €-156,7 k €-842 €-901 €
Balance sheet
Equity396,2 k €394,6 k €390,5 k €47,2 k €48,1 k €
Total assets1,7 M €1,6 M €1,6 M €1,4 M €1,3 M €
Cash91,2 k €114,1 k €55,8 k €12,1 k €37,2 k €
Debts1,3 M €1,2 M €1,2 M €1,4 M €1,3 M €
Other
Workforce5,7 ETP5,0 ETP4,0 ETP4,0 ETP4,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 5 ended

Active mandates

FREDERIC GERMAIN

Mandate

Active

Ended mandates

DUP

Director · since 20 février 2018 · 0578.843.441

Represented by CHANTAL BOSMANS

Ended
INNOVENTIS GCV

Director · since 20 février 2018 · 0478.636.996

Represented by FREDERIC GERMAIN

Ended
DUP

Mandate · 0578.843.441

Ended
FREDERIC GERMAIN

Director

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date26/07/202615/12/202515/06/202429/08/202303/11/202209/12/2021
General meeting29/05/202630/05/202531/05/202431/05/202331/05/202231/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 8 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202529/05/202626/07/2026DutchPDF
Abridged model31/12/202430/05/202515/12/2025DutchPDF
Abridged model31/12/202331/05/202415/06/2024DutchPDF
Abridged model31/12/202231/05/202329/08/2023DutchPDF
Abridged model31/12/202131/05/202203/11/2022DutchPDF
Abridged model31/12/202031/05/202109/12/2021DutchPDF
Abridged model31/12/201930/06/202008/08/2020DutchPDF
Micro model31/12/201831/05/201911/07/2019DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 5 ended

Active mandates

FREDERIC GERMAIN

Mandate

Active

Ended mandates

DUP

Director · since 20 février 2018 · 0578.843.441

Represented by CHANTAL BOSMANS

Ended
INNOVENTIS GCV

Director · since 20 février 2018 · 0478.636.996

Represented by FREDERIC GERMAIN

Ended
DUP

Mandate · 0578.843.441

Ended
FREDERIC GERMAIN

Director

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office14/04/2025
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - BENAMING - MAATSCHAPPELIJKE ZETEL - DOEL
    PDF
  • Mandates27/02/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - DIVERSEN - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates20/04/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other23/02/2018
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20251,6 k €↓
  2. 2024
    Annual accounts 20244,1 k €↑
  3. 2024
    Name changeINNOVENTIS PHARMA
  4. 2023
    Annual accounts 2023-156,7 k €↓
  5. 2022
    Annual accounts 2022-842 €↑
  6. 2021
    Annual accounts 2021-901 €↓
  7. 2021
    Name changeINNOVENTIS ONE
  8. 2020
    Annual accounts 20205,4 k €↓
  9. 2019
    Annual accounts 20195,5 k €↑
  10. 2018
    Annual accounts 2018-23,5 k €
  11. 21/02/2018
    IncorporationPublic limited company